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Background & Aims: Crohn’s disease is characterized that Crohn’s disease is a genetically determined, unre-
by unrestrained inflammation with a genetic compo- strained inflammatory response to ubiquitous luminal
nent. Genetic susceptibility and activation of the kalli- bacteria or bacterial components.2 Investigation of the
krein-kinin (contact) system were investigated in exper- pathogenesis of this disease has been limited by the lack
imental enterocolitis and extraintestinal inflammation of an animal model that shows a chronic, spontaneously
induced by bacterial polymers. Methods: Kinetics of relapsing course; transmural granulomatous inflamma-
inflammation in inbred Lewis and Buffalo rats injected
tion; and differential genetic susceptibility in inbred ro-subserosally with peptidoglycan-polysaccharide poly-
dent strains.mers were correlated with in vivo and in vitro activation
We have developed a rat enterocolitis model thatof the contact system. Results: Lewis rats had a bipha-
shows these characteristics, thereby permitting detailedsic course of enterocolitis. Acute inflammation peaked
examination of the mechanisms of genetically determined1 day after injection, gradually decreasing until day 14
when intestinal inflammation spontaneously reacti- chronic intestinal inflammation.3–5 In this model, puri-
vated and persisted for 16 weeks, accompanied by fied peptidoglycan-polysaccharide (PG-PS) polymers are
arthritis, granulomatous hepatitis, anemia, and leuko- injected intramurally (subserosally) into the wall of the
cytosis. Self-limited acute enterocolitis in Buffalo rats distal ileum, cecum,3,4 or distal colon.5 PG-PS is the
resolved by 24 days without extraintestinal involve- primary structural component of nearly all bacteria, in-
ment. Consumption of the precursor proteins prekalli-
cluding those found in high concentrations within thekrein and high-molecular-weight kininogen indicated ac-
distal ileum and colon.6 PG-PS derived from group Ativation of the plasma contact system in Lewis rats and
streptococci (PG-APS) is used as the prototype of poorlyclosely correlated with chronic intestinal inflammation.
biodegradable bacterial cell wall polymers capable of in-Contact system activation did not occur in Buffalo rats,
ducing chronic granulomatous inflammation, althougheven during acute inflammation. In vitro studies
showed a decreased rate of kininogen cleavage in Buf- PG-PS derived from intestinal bacteria, including those
falo plasma. Conclusions: Selective in vivo and in vitro isolated from patients with Crohn’s disease, can also cause
activation of the contact system in susceptible Lewis chronic experimental inflammation.6–8 Acute intestinal
rats suggests that this pathway is one determinant of inflammation develops at the site of subserosal injection
genetic susceptibility to granulomatous enterocolitis in all rat strains investigated, but chronic, granulomatous
and systemic complications. enterocolitis is restricted to certain susceptible strains.3,4
Lewis and Sprague–Dawley rats develop chronic in-
flammation, whereas Buffalo and Fischer F344 rats haveC self-limited enterocolitis with no evidence of spontaneousrohn’s disease is characterized by chronic, spontane-ously relapsing granulomatous enterocolitis associ-
reactivation of inflammation. These inbred rat strains alsoated with extraintestinal inflammation and activation of
show differential susceptibility to systemic inflammationalmost every limb of the inflammatory response.1,2 This
idiopathic disorder shows both genetic and environmen-
Abbreviations used in this paper: PG-APS, peptidoglycan-polysac-tal components. Its preferential location in the distal
charide derived from group A streptococci; PG-PS, peptidoglycan-ileum and colon, which are areas of the highest luminal
polysaccharide.
bacterial colonization, and improvement when bacterial  1996 by the American Gastroenterological Association
0016-5085/96/$3.00concentrations are decreased has led us to hypothesize
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after intraperitoneal injection of PG-APS.6 Lewis rats genetic susceptibility in the pathogenesis of experimental
intestinal inflammation by comparing the time course ofhave spontaneous reactivation of erosive peripheral arthri-
tis approximately 2 weeks after a single intraperitoneal the response to intramurally injected PG-APS in two
inbred rat strains: Lewis and Buffalo. A secondary objec-injection of PG-APS, associated with hepatic granulomas
and anemia, but no evidence of intestinal injury.6,9–11 tive was to determine whether the contact system partici-
pated in experimental granulomatous enterocolitis andLewis rats are high responders to several other experi-
systemic inflammation and whether it could be one ofmental inflammatory models, including adjuvant- and
the mechanisms of the differential genetic responses. Tocollagen-induced arthritis,12 indomethacin-induced en-
quantify the inflammatory response, we evaluated macro-terocolitis,13 hepatobiliary inflammation associated with
scopic, histological, and biochemical indices of intestinalexperimental small bowel bacterial overgrowth,14 respira-
inflammation, hematocrits, white blood cell counts, andtory mycoplasmosis,15 and autoimmune encephalitis.16
the presence of arthritis and hepatic granulomas. To doc-Two hypotheses have been advanced to explain enhanced
ument in vivo activation of the contact system and thesensitivity of Lewis rats to chronic inflammation: defec-
systemic inflammatory response, we determined thetive regulation of the hypothalamic/pituitary/adrenal
plasma levels of plasma prekallikrein, factor XI, high-axis9 and an abnormal balance of interleukin 1 and in-
molecular-weight kininogen, T kininogen (the majorterleukin 1 receptor antagonist.4,17 The consequences of
acute-phase protein of the rat), and a1–inhibitor 3 pro-defective immunoregulation by either of these two mech-
tein (a negative acute-phase protein of the rat)28 at variousanisms is an inappropriately aggressive inflammatory re-
time points corresponding to acute and chronic phasessponse mediated by soluble products of effector immune
of inflammation. We correlated the degree of intestinalcells and activation of the complement and contact sys-
inflammation with activation of the contact system pro-tem cascades.
teins. Finally, we examined in vitro activation of kalli-PG-APS induces the production of inflammatory me-
krein and cleavage of high-molecular-weight kininogendiators, such as anaphylatoxins (C3a and C5a),18 eicosa-
in the two rat strains. These studies show spontaneousnoids,19 and cytokines.4 We have recently shown that
reactivation of enterocolitis, presence of granulomas andintraperitoneal injection of PG-APS in Lewis rats acti-
extraintestinal inflammation, and selective activation ofvates the contact system,20 which results in plasma kalli-
the contact system in susceptible Lewis rats.krein formation and release of the inflammatory mediator
bradykinin. Furthermore, we have shown that inhibition Materials and Methods
of plasma kallikrein attenuates acute PG-APS–induced
The chromogenic substrates S-2302 (kallikrein), S-arthritis.21 The plasma contact activation system com-
2366 (factor XIa), S-2238 (thrombin), and plasma prekalli-prises factor XII, factor XI, plasma prekallikrein, and
krein activator were purchased from Pharmacia (Franklin, OH).high-molecular-weight kininogen and is responsible for
Microplates (tissue culture treated no. 3072 or 3075) were
the surface-mediated defense reactions.22 Activation of obtained from Falcon Plastics (Mt. Laurel, NJ). Human serum
this system is characterized by conversion of plasma pre- albumin and rat albumin were both purchased from Sigma
kallikrein to kallikrein with a decrease in plasma prekal- Chemical Co. (St. Louis, MO).
likrein, cleavage of high-molecular-weight kininogen by
Cell Wall Preparationkallikrein to liberate bradykinin, and activation of factor
XI to factor XIa, which destroys the coagulant activity PG-APS polymers with a molecular weight ranging
of high-molecular-weight kininogen.23 Although regula- from 5 1 106 to 5 1 107 daltons were prepared from the cell
walls of group A, type 3, strain D58 streptococci (Streptococcustory mechanisms such as protease inhibitors and cellular
pyogenes) as described previously.4,29 Immediately before injec-clearance operate during pathological conditions, these
tion, the cell walls were diluted to appropriate concentrationsmodulating systems are not sufficient to prevent forma-
in phosphate-buffered saline and sonicated for 30 seconds intion of its active components. Kallikrein, which results
a water bath to disperse aggregates. Aseptic techniques werefrom plasma prekallikrein activation by activated factor
used, and sterility was confirmed by culturing 0.1 mL on sheepXII, is a chemoattractant for neutrophil,24 and stimulates
blood agar. Rhamnose was assayed by the method of Dische
neutrophil aggregation25 and elastase release.26 Moreover, and Shettles30 and used to calculate final PG-APS polymer
kallikrein hydrolyzes high-molecular-weight kininogen, concentrations.
which releases bradykinin, a nonapeptide that induces
Experimental Protocolvasodilation, increased vascular permeability, hypoten-
sion, and intestinal chloride secretion.27 A total of 135 inbred specific pathogen–free female
rats, weighing 135–155 g (6–7 weeks of age), were used forThe first goal of this study was to ascertain the role of
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the in vivo studies. Seventy Lewis rats were obtained from ture20 and then was stored at 070C. A separate sample of
cardiac blood was taken for hematologic measurements.Charles River Breeding Laboratories Inc. (Raleigh, NC), and
65 Buffalo rats were purchased from Simonson Laboratories
Histological Inflammatory Score(Gilroy, CA). Rats were housed together in a specific patho-
gen–free room for 5–10 days before surgery was performed Blinded histological assessment of acute and chronic
and for the duration of these studies. Rats were maintained in inflammation was performed using a modification of our pre-
isolation, fed standard rat chow and water, and periodically viously validated scoring system.3,4 Values of 0–4 (4 being
tested for serological and culture evidence of recognized rodent the most severe) were assigned using our previously described
pathogens. Plasma was obtained from 5 separate Lewis and 5 criteria3 for acute and chronic inflammatory cell infiltrations
Buffalo rats for the in vitro studies. Rats were maintained at each site. Acute and chronic scores were assigned for each
under specific pathogen–free conditions and allowed free access of the four injection sites (Peyer’s patch, distal ileum, cecal
to food and water during the course of the experiments. Intes- tip, and midcecum), and the results were summed so that the
tines were exposed by laparotomy using aseptic technique after maximal score was 32. The presence of mucosal ulceration,
induction of anesthesia by intramuscular injection of 1.3 mL/ crypt abscesses, and granulomas was noted.
kg body wt Innovar (Pitman-Moore Co., Washington Cross-
ing, NJ). Lewis or Buffalo rats were injected intramurally Myeloperoxidase Assay
(subserosally) with either PG-APS (45 mg dry wt and 15 mg
Intestinal myeloperoxidase activity was determined us-
rhamnose/g body wt) or human serum albumin (45 mg/g) as
ing a minor modification of the method of Grisham et al.31
described previously.4 At each site, 0.05 mL (one ninth of total
Briefly, intestinal tissue was homogenized in 20 mmol/L phos-
dose) was injected 2 and 4 cm proximal to the ileocecal valve
phate buffer (pH 7.4) and centrifuged at 6000g for 20 minutes
at the junction of the mesentery and ileum, into two distal at 4C. The pellet was homogenized and sonicated with an
ileal Peyer’s patches, and into the lymphoid aggregate at the equivalent volume of 50 mmol/L potassium phosphate buffer
cecal tip. Two midcecal sites were injected subserosally with (pH 6.0) containing 0.5% (wt/vol) hexadecyltrimethylammo-
0.1 mL each of PG-APS or human serum albumin. The abdom- nium hydroxide. Myeloperoxidase activity was determined by
inal cavity was closed in two layers with absorbable (perito- measuring the H2O2-dependent oxidation of 3,35,5-tetra-
neum and muscle layers) and silk (skin) sutures. Four to six methylbenzidine and normalized for tissue weight.
rats from each group were killed by CO2 narcosis at 1, 5, 8,
14, and 24 days and 6, 8, 12 and 16 weeks postinjection. A Assays of Coagulation and Contact
group of 10 normal Lewis rats served as assay controls as well Activation
as a source of pooled normal rat plasma.
Antithrombin III was measured by a functional ami-
dolytic microplate assay using the Coatest Antithrombin KitAssessment of Inflammation and
(Helena Laboratories, Beaumont, TX).32 Prekallikrein levels
Collection of Specimens were determined by a functional amidolytic assay described
previously.33 Factor XI functional activity was determined by aRats were weighed twice weekly for 2 weeks and then
method developed in this laboratory.34 High-molecular-weightweekly for the duration of the experiment. Ankle joints were
kininogen coagulant activity was determined by a slight modi-scored for swelling and erythema on a 0–4 scale11 when the rats
fication of the method of Proctor and Rapaport35 using humanwere weighed. At necropsy, performed by blinded observers,
total kininogen deficient plasma.36intestinal and systemic inflammation was determined by gross
examination, white blood cell counts, and hematocrits on car-
Determination of T-Kininogen anddiac blood, myeloperoxidase, analysis of intestinal specimens,
a1–Inhibitor 3 in Rat Plasmaand histological evaluation. A gross gut score was calculated
using the sum of 0–4 determinations of intestinal wall thick- T-kininogen and a1–inhibitor 3 were measured by
ening, adhesions, mesenteric contraction, and serosal nodules sandwich enzyme-linked immunosorbent assays.37 T-kinino-
as described previously.3,4 Hepatic granulomas were quanti- gen was purified as described previously.38 Purified a1–inhibi-
tated on a 0–4/ scale. Samples from each intestinal injection tor 3 was purified according to the method of Moreau et al.39
site were collected on dry ice and stored at 070C for myelo- Polyclonal antibodies were developed against T-kininogen and
peroxidase assay and fixed in 10% buffered formalin for histo- a1–inhibitor 3.
37 The polyclonal immunoglobulin Gs were
logical processing. Blood samples were aspirated from the right isolated from the immune sera by the use of affinity chromatog-
ventricle by an 18-gauge needle into a syringe containing 0.1 raphy on protein G, according to the recommendations of the
mol/L sodium citrate (final ratio of citrate to blood was 1:9) manufacturer (Pharmacia, Uppsala, Sweden). The purity of this
for biochemical measurements of the kallikrein-kinin system material was monitored using absorbance ratio 278:252 nm
in rats killed 5, 24, and 42 days after PG-APS or human serum (ú1.5) and its recovery at 278 nm. The purified proteins
albumin injection. Plasma was isolated by double centrifuga- (immunoglobulins) were used for the coating of plates and for
labeling. Fifteen milligrams of these purified immunoglobu-tion of citrated blood in polypropylene tubes at room tempera-
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lins was labeled with horseradish peroxidase (Boehringer performed according to the method of Laemmli44 on 4%–20%
polyacrylamide gradient gels (Bio-Rad Laboratories, Rich-Mannheim, Indianapolis, IN) using the method described by
Tijssen.40 Nunc immunoplates (Nunc, Roskilde, Denmark) mond, CA) using a Hoefer SE apparatus. The plasma proteins
were then electrotransferred to a polyvinyl difluoride mem-were coated for 18 hours at 4C with 100 mL of affinity purified
immunoglobulin G (5 mg/mL) diluted in 100 mmol/L sodium brane using a Trans-blot SD semidry transfer cell (Bio-Rad
Laboratories, Hercules, CA) at a constant current of 240 mAcarbonate buffer, pH 9.2. The plates were then washed five
times in incubation buffer (containing 50 mmol/L Tris HCl; for 45 minutes. The membrane was blocked overnight with
10% nonfat Irish cream at 4C on a rotary shaker and then100 mmol/L NaCl, pH 7.4; and 0.05% Tween 20) and satu-
rated for 1 hour at 37C with 200 mL of incubation buffer. incubated with purified, biotin-labeled anti–high-molecular-
weight kininogen antibodies in phosphate-buffered saline–The plates were washed and incubated for 3 hours at 37C
with 100 mL of the biological samples or the standard diluted Nonidet P40 (Boehringer Mannheim) for 2 hours. After exten-
sive washing, the polyvinyl difluoride membrane was incu-in the incubation buffer. The plates were then washed again
and incubated for 3 hours at 37C with 100 mL of labeled bated with avidin-alkaline phosphatase (Sigma Chemical Co.)
in phosphate-buffered saline–Nonidet P40 for 1 hour. Finally,immunoglobulin Gs diluted 1:4000 in the incubation buffer.
After further washing, the presence of immune complexes was 5-bromo-4-chloro-3 indoyl phosphate/nitroblue tetrazolium
chloride phosphate substrate (Kirkegaard/Perry Laboratories)detected by the addition of 100 mL of substrate solution (100
mmol/L orthophenylene diamine; Sigma Chemical Co.) and was added to develop the membrane.
0.01% urea hydrogen peroxide (from Sigma Chemical Co.), in Amidolytic assay for kallikrein generation. Fifty mi-
citrate buffer (0.08 mol/L, pH 5). After 30 minutes at 25C, croliters of pooled Lewis and Buffalo rat plasma either inacti-
absorbances were measured at 450 nm using 650 nm as the vated (baseline, 0 point) or activated by kaolin (at 1, 3, 6, and
reference wavelength. 15 minutes) was transferred to a microplate containing 50 mL
of 2 mmol/L S-2302. After a 10-minute incubation, the sub-
In Vitro Activation of Kallikrein and Kinin strate hydrolysis was stopped by the addition of an equal vol-
ume of 50% acetic acid. The absorption was read at 405 nmRabbit antiserum against rat high-molecular-weight
in a microplate reader and converted to micromoles of substratekininogen (obtained from Dr. A. Adam) was purified using a
hydrolyzed per minute by reference to a p-nitroaniline standardprotein A purification column.41 The purified immunoglobu-
as described previously (AB Kabi Diagnostica, Stockholm,lins were labeled with biotin according to the method of Hock
Sweden).33et al.42 In brief, the protein was dialyzed against 0.1 mol/L
NaHCO3, pH 8.0, and diluted to 1 mg/mL by the addition
Statistical Analysisof the same buffer. One hundred liters of 1 mg/mL of biotin-
e-aminocapronyl-N-hydroxysuccinimide in dimethyl sulfoxide A group of animals (n Å 10) that received neither
was added to 1 mL of the protein solution (molar ratio of saline nor PG-APS was used to normalize the contact system
protein/biotin, 1:18). After incubation for 4 hours at 23C, data from the control groups (human serum albumin injected)
the mixture was dialyzed against phosphate-buffered saline. or the PG-APS–treated groups. Differences between control
The specificity and sensitivity of antibody reactivity to high- groups at different intervals for biochemical parameters were
molecular-weight kininogen were analyzed by Western blot. evaluated by the two-way analysis of variance method of New-
The antibodies were found to cross-react with rat serum albu- man–Keuls45 to validate the data. The unpaired two-tailed
min and to cross-react weakly with T-kininogen. Student’s t test was then used to evaluate differences between
The contact system of citrated pooled Lewis or Buffalo rat control and treated groups at each interval. P values of °0.05
plasma was activated by incubation with 1 mg/mL kaolin were considered significant. Correlations between high-molec-
(Fisher Laboratories) in phosphate-buffered saline in proportion ular-weight kininogen or plasma prekallikrein activity from
(9:1, vol/vol) or purified human plasma kallikrein (0.2 mmol/ the PG-APS–treated group with their corresponding clinical
L) prepared as described previously43 at 23C. At 3-, 6-, and gross gut, joint, and hepatic granuloma scores were evaluated
15-minute intervals, aliquots of the incubation mixture were by linear regression analysis.
removed for Western blot analysis of high-molecular-weight
kininogen and kallikrein assay. Results
Western blot of high-molecular-weight kininogen
cleavage using anti–high-molecular-weight kininogen anti- Intestinal Inflammation
bodies. Two microliters of either pooled Lewis and Buffalo
Both Lewis and Buffalo rats developed acute in-rat plasma inactivated (0 time point) or activated with kaolin
flammation at the injection site manifested by edema,or human plasma kallikrein at indicated time intervals was
hemorrhage, thickening of the bowel wall and mesentery,transferred to sample buffer containing sodium dodecyl sulfate.
and adhesions. Acute intestinal inflammation peaked atPlasma from a brown Norway rat strain (BN/Mai Pfd) deficient
1 day after PG-APS injection and slowly diminished overin both high-molecular-weight kininogen and low-molecular-
weight kininogen was used as a control. Electrophoresis was 8 days, as indicated by blinded gross gut scores (Figure
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intestinal wall, serosal nodules, and enlarged mesenteric
lymph nodes. Chronic inflammation was diffuse in the
cecum and distal ileal mesentery and clearly occurred
between injection sites. Chronic enterocolitis persisted
for at least 16 weeks in Lewis rats. In striking contrast,
gross inflammatory scores in Buffalo rats diminished by
2 weeks and did not relapse over the 16-week period of
observation. Buffalo rats did not develop serosal granulo-
mas, bowel wall thickening, or dense adhesions, although
residual adhesions and mesenteric contractions remained
for the duration of the study as a consequence of the
acute inflammatory response.
Histological assessment of inflammation confirmed the
gross observations. Both Lewis and Buffalo rats showed
acute focal inflammation at the site of injection, with
neutrophils and macrophages being the most predomi-
nant infiltrating cells. Focal necrosis was frequently ob-
served in the submucosa and mesentery; mucosal ulcer-
ation was quite rare. Beginning 14 days after PG-APS
injection, Lewis rats developed chronic, granulomatous
enterocolitis with extensive fibrosis. Inflammation was
most marked in the submucosa, serosa, and mesentery,
but granulomas in the lamina propria, crypt abscesses
(50% of rats), and occasional fissure-like mucosal ulcers
indicated active mucosal inflammation. Mononuclear
cells predominated but focal accumulations of neutro-
phils and crypt abscesses were present at all time points
(Table 1). In contrast, Buffalo rats developed aggressive
acute inflammation but had very limited evidence of
chronic granulomatous enterocolitis. Blinded histological
intestinal inflammatory scores showed different kinetics
Figure 1. Clinical and histological evidence of intestinal inflammation of inflammation in the inbred rat strains (Figure 1B and
in Lewis (
 
) and Buffalo () rats at intervals after a single subserosal C ). Buffalo rats had a more protracted acute phase (14injection with PG-APS (45 mg/g body wt). (A) Gross inflammation. (B)
days) of enterocolitis that resolved by 24 days. TotalAcute histological inflammation. (C) Total histological inflammation.
(A) Blinded gross gut scores were calculated as the sum of serosal inflammatory scores in Buffalo rats continued to resolve
nodules, adhesions, bowel wall thickening, and contracted mesentery over a 16-week period. In contrast, Lewis rats had acute
as described in Materials and Methods. (B and C) Blinded histological
inflammation that diminished by 8 days but spontane-intestinal inflammatory scores after subserosal PG-APS injection in
Lewis and Buffalo rats. (B) Acute-phase histological inflammatory ously reactivated 14 days after a single PG-APS injection
score is based on the degree of infiltration with neutrophils, tissue and remained active for at least 16 weeks. By 16 weeks,
necrosis, and edema. (C) The total histological inflammatory score
40% of Lewis rats had histological evidence of acutewas calculated by adding the acute-phase and chronic-phase compo-
inflammation, as opposed to 100% at 6 and 12 weeks.nents of each injection site. Values are expressed as mean { SEM.
*P ° 0.02, **P õ 0.001, †P Å 0.006 vs. Buffalo rats. Histological scores for human serum albumin–injected
controls ranged from 3.6 { 0.2 at 4 days to 0.6 { 0.2
by 6 weeks after injection; no difference in histological
scores was noted between Lewis and Buffalo control rats.1A ). During the acute phase, Buffalo rats had consis-
tently higher gross scores than Lewis rats. Human serum Cecal myeloperoxidase values provided biochemical
confirmation of biphasic, spontaneously reactivating in-albumin–injected rats had scores ranging from 0 to 2,
with a mean score of 0.4 { 0.3 for Lewis rats and 0.5 { flammation in Lewis rats and self-limited injury in Buf-
falo rats (Figure 2). Furthermore, tissue myeloperoxidase0.4 for Buffalo rats. Beginning around 14 days after
PG-APS injection, Lewis rats spontaneously developed concentrations showed the more protracted course of
acute inflammation in Buffalo rats, which showed peakchronic enterocolitis with dense adhesions, thickening of
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Table 1. Incidence of Relapsing Enterocolitis and Extraintestinal Inflammation in Inbred Rats 14 Days or Longer After PG-APS
Injection
Intestinal granulomas Acute gut inflammation Hepatic granulomas Arthritis Anemia Leukocytosis
Buffalo rats 11a 26b 4 0 11 13
Lewis rats 91 87 73 84 84 100
NOTE. Acute gut inflammation is defined by a histological score of acute inflammation of ú2.
aPercent of rats injected subserosally with PG-APS.
bAll slides showing acute inflammation were from rats killed 14 days after PG-APS injection.
biochemical values at 14 days after PG-APS injection rarely in the forepaws. Histological examination showed
erosion of the articular cartilage with pannus formation,compared with peak acute values on day 5 in Lewis rats.
By 6 weeks, however, myeloperoxidase values in Lewis exudate in the synovial space, hyperplasia of the synovial
lining, and granulomatous inflammation in therats were significantly higher than in Buffalo rats, which
had returned to control values. Control cecal myeloperox- periarticular tissue. Hepatic granulomas were macro-
scopically evident and consisted of well-defined aggre-idase concentrations were 0.41 { 0.09 in Lewis rats in-
jected with human serum albumin and 0.71 { 0.24 in gates of mononuclear cells with concentric fibrosis and
Buffalo rats. occasional central necrosis. Granulomas were frequently
located near portal tracts but also occurred in the paren-
Systemic Inflammation
chyma. Hepatic granulomas were not observed before
A marked disparity existed in the incidence of 14 days after PG-APS injection in Lewis rats and became
extraintestinal manifestations in Lewis and Buffalo rats more fibrotic with fewer inflammatory cells by 16 weeks.
(Figure 3). Arthritis and hepatic granulomas occurred Splenic enlargement and necrosis was observed in both
in 73% of Lewis rats examined 14 days or more after rat strains beginning around 8 days after gut injection
PG-APS injection; however, only 4% of Buffalo rats of PG-APS.
developed hepatic granulomas, and arthritis was not evi- Like intestinal inflammation, anemia and leukocyto-
dent in Buffalo rats (Table 1). Arthritis was predictably sis persisted for the duration of the experiment in Lewis
observed in the rear ankle joints of Lewis rats and only rats and were self-limited but more pronounced in the
acute phase of inflammation in Buffalo rats (Figure 4).
It should be noted that control hematocrit values were
greater in Lewis rats than Buffalo rats injected with
human serum albumin (Figure 4A ), but control white
blood cell count concentrations were similar in the two
Figure 3. Incidence of systemic inflammation in inbred rats at inter-Figure 2. Cecal myeloperoxidase (MPO) concentrations in Lewis (
 
)
and Buffalo () rats at intervals after subserosal injection of PG-APS. vals after subserosal injection of PG-APS. The percentage of rats with
systemic inflammation relative to the total number of rats injectedMyeloperoxidase values were normalized by tissue sample weights
(in grams). *P ° 0.05, **P ° 0.01 vs. Buffalo rats. with PG-APS at each time point is shown.
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(Figures 1 and 2) clearly show that Lewis rats had sponta-
neously reactivating intestinal inflammation. The active
nature of chronic enterocolitis in Lewis rats is further
documented by histological detection of intestinal neu-
trophils and granulomas in the great majority of Lewis
rats (Table 1). The first indications of reactivating in-
flammation around 14 days after PG-APS injection were
a 5–10 g weight loss, lethargy, bloody conjuctiva and
nostrils, and scruffy fur. These findings preceded the
onset of arthritis by 1–3 days. Arthritis or hepatic granu-
lomas were never found in the absence of intestinal gran-
ulomas, although gut lesions were observed occasionally
without joint or hepatic lesions, suggesting that gut le-
sions predated the onset of arthritis and hepatobiliary
disease. By all criteria, no active inflammation was evi-
dent in Buffalo rats 24 days or more after PG-APS injec-
tion.
Acute-Phase Proteins
Biochemical assays of plasma acute-phase re-
actants, contact system proteins, and indicators of hepatic
protein synthesis were measured at representative time
points during the acute (5 days) and chronic (24
and 42 days) phases of inflammation. T-kininogen repre-
sents a major acute-phase protein in the rat. T-kininogen
levels increased in the PG-APS–treated Lewis rats from
0.97 { 0.41 mg/mL to 2.3 { 0.53 mg/mL by day 5
and peaked at 6.8 { 3.3 mg/mL on day 24 (Figure 5A ).
By day 42, T-kininogen levels decreased to 3.9 { 1.4
mg/mL but remained significantly higher than control
levels. No significant changes were observed in PG-APS–
treated Buffalo rats or human serum albumin–injected
controls.
a1–Inhibitor 3 represents a negative acute-phase pro-Figure 4. Hematologic parameters in Lewis and Buffalo rats after
tein in the rat. a1–Inhibitor 3 baseline levels were foundsubserosal PG-APS injection () or human serum albumin injection
(). (A) Hematocrit values on cardiac blood were transiently de- to be consistently lower in the human serum albumin–
creased in Buffalo rats after PG-APS injection, but chronic anemia treated Buffalo rats than in the control Lewis rats (Figure
persisted for the duration of the experiment only in Lewis rats. *P õ
5B ). The a1–inhibitor 3 concentrations in the PG-APS–0.05, **P õ 0.001 vs. human serum albumin injected. (B) White
blood cell counts (WBC) were persistently elevated only in Lewis rats. injected Lewis rats decreased significantly during chronic
*P õ 0.05, **P õ 0.001 vs. human serum albumin injected. Lewis inflammation (days 24 and 42) when compared with their
rats (
 
) compared with Buffalo rats () during the chronic phase of
respective human serum albumin–treated controls. InPG-APS–induced inflammation. *P Å 0.01, **P õ 0.001 vs. Buffalo
contrast, a1–inhibitor 3 levels in Buffalo rats injectedrats.
with PG-APS showed no difference from control values
at any time point, despite the presence of active, acute
inflammation at day 5.inbred strains (7.6 1 103/mL Lewis rats and 7.9 1 103/
mL Buffalo rats).
Biochemical Assays of Contact System
ProteinsSpontaneous Reactivation of Enterocolitis
in Lewis Rats Prekallikrein levels were significantly lower in
PG-APS–treated Lewis rats compared with controls orThe biphasic course of the gross and histological
gut inflammatory scores and myeloperoxidase values Buffalo rats during both acute and chronic phases of
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inflammation (Figure 6A ). By day 5, the concentrations lyzed groups in this study (data not shown). Because
plasma antithrombin III may be markedly depleted bydecreased from 82.7% { 2.5% (human serum albumin–
injected controls) to 67.1% { 1.2% (P õ 0.01) and disseminated intravascular coagulation or decreased be-
cause of lack of synthesis in severe liver disease, it isremained lower than control levels through day 42
(68.9% { 2.4%). No changes in prekallikrein concentra- likely that neither of these conditions account for the
observed changes in contact system proteins.tions were evident in Buffalo rats injected with PG-APS
at any time point, including during active inflammation Correlation of Clinical and Biochemical
at 5 days. Factor XI levels were not affected in either Results
strain (data not shown).
Biochemical measures of contact system activita-We observed a biphasic decrease in the functional levels
tion were correlated with clinical parameters by linearof high-molecular-weight kininogen in Lewis rats injected
regression analysis. During the chronic phase, gross gutwith PG-APS (Figure 6B). High-molecular-weight kinino-
scores, arthritis, and hepatic granulomas closely corre-gen levels were significantly decreased in PG-APS–treated
lated with plasma prekallikrein and high-molecular-Lewis rats on day 5 (63.6% { 6.6% vs. 101.0% { 12.4%
weight kininogen values (individual correlations rangingfrom its respective control group) and day 42 (58.8% {
from r Å 00.74 [P Å 0.01] to r Å 00.94 [P õ 0.001])6.4% vs. 104.4% { 11.4% from its respective control
42 days after PG-APS injection. At this time point,group) but not at the 24-day time period. These results are
plasma prekallikrein and high-molecular-weight kinino-in direct contrast to stable plasma high-molecular-weight
gen values were significantly correlated with each otherkininogen concentrations in Buffalo rats injected with PG-
(r Å 0.71; P Å 0.016). Plasma prekallikrein values corre-APS at all time points, even during active gross and histo-
lated with clinical scores 24 days after PG-APS injection,logical inflammation at day 5.
but high-molecular-weight kininogen values did not. No
Antithrombin III such correlation was observed during the acute phase of
There were no significant differences between
functional levels of antithrombin III in any of the ana-
Figure 5. Biochemical assays of plasma acute-phase reactants. (A) T-
kininogen levels were elevated in Lewis rats injected with PG-APS during
acute and chronic phases of inflammation but unchanged in Buffalo rats.
*P õ 0.05. (B) a1–inhibitor 3 protein, a negative acute-phase reactant, Figure 6. Functional assays of contact system proteins. (A) Prekalli-
krein and (B) high-molecular-weight kininogen levels are expressedwas decreased in Lewis rats but not in Buffalo rats injected with PG-
APS relative to human serum albumin–injected rats. *P õ 0.01. , as a percentage of pooled normal rat plasma values. *P õ 0.01. ,









rats / human serum albumin; , Buffalo rats / PG-APS. Buffalo rats / human serum albumin; , Buffalo rats / PG-APS.
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PG-APS–induced inflammation because of the lack of
prekallikrein and high-molecular-weight kininogen acti-
vation in Buffalo rats with acute enterocolitis.
In Vitro Activation of Kallikrein and
Kininogen by Kaolin
To determine whether the observed lack of plasma
prekallikrein and high-molecular-weight kininogen con-
sumption in Buffalo rats was caused by a failure of activa-
tion of the contact system or a more rapid inhibition of
this cascade, we activated the contact system in vitro
with kaolin.
Analysis of high-molecular-weight kininogen
cleavage by Western blotting. As shown in Figure 7A
under reducing conditions, single-chain high-molecular-
weight kininogen (molecular weight, 120 kilodaltons)
was visualized in both Lewis and Buffalo plasma. In con-
trast, the kininogen-deficient brown Norway plasma
sample did not show a band corresponding to high-mo-
lecular-weight kininogen. Although the volume of
plasma is identical, the Buffalo rat seems to have a higher
concentration of high-molecular-weight kininogen than
the Lewis rat. In Lewis rat plasma, the high-molecular-
weight kininogen band is progressively decreased after
exposure to kaolin. In Buffalo rat plasma, little change
in intensity is noted. Laser densitometric scanning (Table
2) showed that high-molecular-weight kininogen was
consumed more rapidly and more completely in plasma
from Lewis rats than Buffalo rats. Similar results were Figure 7. (A) In vitro cleavage of high-molecular-weight kininogen (HK) by
found in three separate experiments. The bands indicat- exposure of plasma to kaolin as shown in a Western blot using anti–high-
molecular-weight kininogen antibodies. The 120-kilodalton (kDa) banding the high-molecular-weight kininogen cleavage prod-
across all Lewis and Buffalo plasma lanes but not in the kininogen-ucts, high chain (molecular weight, 62 kilodaltons) and deficient brown Norway (BN) rat plasma lane represents high-molecular-
light chain (molecular weight, 41 kilodaltons), were ob- weight kininogen (120 kilodaltons). The broad bands localized just below
the 83-kilodalton standard across all lanes indicate T-kininogen (TK) andserved in both Lewis and Buffalo lanes but not in brown
albumin (alb.). The band situated above the 44-kilodalton standardNorway plasma. The lower immunologic reactivity of marked across activated samples (3, 6, and 15 minutes) from both
the heavy and light chains do not allow a meaningful Lewis and Buffalo rats but not present in unactivated lanes (0 time point)
or in the brown Norway lane represents the heavy chain of high-molecular-comparison. Thus, this assay indicates that Buffalo rat
weight kininogen (HC-HK; 62 kilodaltons). The delicate band localized just
plasma high-molecular-weight kininogen is cleaved more below the 44-kilodalton standard in Lewis and Buffalo plasma samples
slowly after exposure to an anionic surface (kaolin) com- (but not in the brown Norway lane) represents the light chain of high-
molecular-weight kininogen (LC-HK; 41 kilodaltons). The delicate bandpared with Lewis rat plasma high-molecular-weight ki-
situated just above the 32-kilodalton standard across all lanes repre-
ninogen. sents a nonspecific reaction with alkaline phosphatase (alk. phos.; 32
kilodaltons) that hydrolyzes BCIP/NBT phosphate substrate used to de-Lewis and Buffalo rat plasma samples were assayed
velop the color. Lane 1, plasma from a brown Norway rat (Katholiekfor kallikrein activity, as measured by hydrolysis of a
strain) that is deficient in high-molecular-weight kininogen. Lane 2,
chromogenic substrate S-2302, after kaolin exposure plasma from Lewis rats before kaolin exposure. Lanes 3–5, Lewis rat
plasma 3, 6, and 15 minutes after kaolin activation (note appearance(Figure 7B ). In both Lewis and Buffalo plasma, the kalli-
of the 41- and 62-kilodalton cleavage product). Lane 6, Buffalo ratkrein activity 1 minute after activation was markedly
plasma with no kaolin. Lanes 7–9, plasma samples from Buffalo rats
increased over baseline to 9.8 { 0.8 and 9.4 { 1.5 mmol/ 3, 6, and 15 minutes after kaolin exposure. Mr, molecular weight. This
Western blot is representative of three separate experiments. (B) In vitromin, respectively, and remained increased in samples
kallikrein generation in Lewis () and Buffalo (● ) plasma activated byevaluated after 3 minutes of activation. The degree of
kaolin at the time intervals shown. Kallikrein activity is expressed as a
kallikrein generation was not significantly different in hydrolysis of chromogenic substrate S-2302 (in micromoles per minute).
The values are the mean of triplicate determinations at each time point.Lewis and Buffalo plasma at any time points. The kalli-
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Table 2. Consumption of High-Molecular-Weight Kininogen weight kininogen cleavage product is evident in the
After Kaolin Activation of Plasma From Lewis and Lewis rat plasma at 3 minutes but is not apparent in the
Buffalo Rats Buffalo plasma until 6 minutes. Similar results were
Densitometry values at intervals after activation found in five separate experiments. These data, together
with our results in Figure 7, argue for an intrinsic defect
0 min 3 min 6 min 15 min in high-molecular-weight kininogen to explain the defec-(n Å 3) (n Å 2) (n Å 2) (n Å 3)
tive cleavage by kallikrein.
Lewis rats 100a 96.5 61.5 34.0 { 8.7b
Buffalo rats 100 90.0 90.5 76.6 { 8.8 Discussion
aMean percent of control (0 minutes) value. The rat model of chronic, granulomatous entero-bP õ 0.05 vs. Buffalo rat values. Values are expressed as mean {
colitis induced by intramural injection of PG-APS hasSEM.
several unique features that enhance its relevance to
Crohn’s disease. First, active inflammation persists for at
least 4 months, which is considerably longer than otherkrein activity decreased to 71% of maximal values in
rodent models of induced enterocolitis.47 Colitis inducedsamples after 6 minutes of activation and to 57% and
by trinitrobenzene sulfonic acid and ethanol resolves by51% after 15 minutes of activation in Lewis and Buffalo
4–6 weeks, and granulomas are not a consistent feature.48rat plasma, respectively. This decrease in activity has
Although colonic inflammation persists for at least 6been shown to be caused by the naturally occurring
months in interleukin 2, interleukin 10, and T-cell re-plasma inhibitors C1 inhibitor and a2-macroglobulin.
46
ceptor knockout mice,49–51 for up to 12 months in HLA-This assay indicates that, after exposure to kaolin, similar
B27/b2-microglobulin transgenic rats
52 (R. B. Sartor, un-conversion of prekallikrein to kallikrein occurs in Lewis
published data, March 1996), and for several years inand Buffalo plasma and that inhibitor activity is similar
cotton-topped tamarins,53 inflammation is largely con-in the two rat strains.
fined to the mucosa in these models rather than to theThe decreased rate of cleavage of high-molecular-
transmural pattern of PG-APS–induced inflamma-weight kininogen after kaolin activation could be caused
tion.3,4,47,49–51 Second, enterocolitis after PG-APS injec-by slower formation of kallikrein, which depends on the
tion spontaneously reactivates at a predictable time point.rate of autoactivation by the surface of factor XII, the
Third, intestinal injury is associated with multiorganrate of activation of prekallikrein to kallikrein by factor
systemic inflammation, including arthritis, hepatic gran-XIIa, the rate of inhibition of kallikrein by plasma prote-
ulomas, splenic inflammation, anemia, and leukocytosis.ase inhibitors, or the efficiency of cleavage of HK by
plasma kallikrein. We have excluded the first three of
these possibilities by showing no difference in the rate
of kallikrein formation and its inactivation in plasma
after exposure to kaolin in plasma from the rat strains.
In Vitro Activation of Kininogen by Plasma
Kallikrein
Because the rates of kallikrein formation and inhi-
bition were similar in Lewis and Buffalo rats, we consid-
ered that the relative resistance of Buffalo rat plasma
high-molecular-weight kininogen to cleavage may be
caused by an intrinsic difference in the high-molecular-
weight kininogen molecule. To test this hypothesis, we
examined the cleavage of rat plasma high-molecular-
weight kininogen by purified plasma kallikrein. As
shown in Figure 8, after exposure to kallikrein, the Lewis
Figure 8. In vitro cleavage of high-molecular-weight kininogen (HK) in
rat plasma high-molecular-weight kininogen is cleaved Lewis and Buffalo rat plasma after activation by purified human
plasma kallikrein (0.2 mmol/L). Representative rat plasma samplesmore rapidly than the Buffao rat plasma, as judged by a
are either unactivated (0 time) or activated by kallikrein. The labelingdecrease in the high-molecular-weight kininogen band
of the lines is the same as in Figure 7A. This Western blot is represen-
at as early as 6 minutes and more dramatically at 15 tative of five separate experiments. kDa, kilodaltons; Mr, molecular
weight.minutes. In addition, the high-chain high-molecular-
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Periportal hepatic inflammation has been described in acute intestinal inflammation, anemia, and leukocytosis
with no evidence of spontaneous relapse of enterocolitis,4% of cotton-top tamarins with colitis (B. F. Warren,
unpublished data, June 1995), a frequency much less very little fibrosis, and no arthritis or hepatic granulomas.
Paradoxically, Buffalo rats had a slightly greater degreethan the 73% incidence in PG-APS–injected Lewis rats
examined during the chronic phase of inflammation. and a more protracted course of acute intestinal inflam-
mation than Lewis rats. We have shown previously thatFourth, PG-APS–induced enterocolitis follows different
kinetics and patterns of inflammation in selected inbred Fischer F344 rats develop only self-limited acute enteroco-
litis without extraintestinal inflammation after intramu-rat strains. Finally, in this model, inflammation is in-
duced by an environmentally relevant substance. PG-PS ral PG-APS administration4 or subcutaneous indometha-
cin.13 Similar differential genetic susceptibilities inis found in high concentrations within the lumina of the
distal ileum and colon, and cell wall polymers isolated inbred rat strains are observed in arthritis and hepatic
granulomas after intraperitoneal injection of PG-from normal luminal bacteria can induce chronic in-
flammation.6–8 APS6,9,10 and hepatobiliary inflammation associated with
experimental small bowel bacterial overgrowth.14 In pre-Lewis rats showed spontaneous reactivation of intesti-
liminary studies, C3H/HeJ or C3H/HeN strain mice arenal inflammation after a single intramural injection of
high responders to experimental enterocolitis, such as T-PG-APS. This represents a true reactivation of enterocoli-
cell receptor knockout,51 trinitrobenzene sulfonic acid,55tis rather than persistence of acute inflammation, as indi-
and Citrobacter freundii56–induced colitis, whereas DBA/cated by the biphasic course of the inflammatory re-
2 and C57/BL mice are low responders.51,55,56sponse. Acute gut injury in the Lewis rats peaked 1–5
days after PG-APS injection by gross, histological, and Our results show that responsiveness to activation of
the contact system may be one of the determinants ofbiochemical parameters, was relatively quiescent by 8
days, and dramatically increased around 14 days after a genetic susceptibility to chronic, relapsing intestinal and
systemic inflammation. Even during the acute phase ofsingle PG-APS injection. Reactivation is further docu-
mented by higher gross and histological inflammatory gut inflammation (5 days after PG-APS injection), when
Buffalo rats showed a greater degree of inflammationscores during chronic phases of inflammation compared
with acute values. Whether individual rats undergo mul- than Lewis rats, there was no consumption of plasma
prekallikrein and high-molecular-weight kininogen intiple exacerbations and remissions of enterocolitis anala-
gous to the relapsing and remitting course of arthritis Buffalo rats, in contrast to significant decreases in these
precursor molecules in Lewis rats. Evidence of activationin Sprague–Dawley rats after intraperitoneal PG-APS
injection6 is difficult to determine because we measured of the contact system persisted 24 days and 6 weeks after
PG-APS injection in Lewis rats, corresponding to earlygut injury only at the time of necropsy. However, arthri-
tis after intramural intestinal injection shows a progres- phases and midphases of chronic enterocolitis, respec-
tively. Moreover, there was decreased cleavage of high-sive course with onset approximately 14 days after PG-
APS injection, in contrast to the biphasic course of molecular-weight kininogen in plasma from Buffalo rats
in response to in vitro activation, indicating an intrinsicarthritis in Lewis rats after intraperitoneal PG-APS injec-
tion.6,9,20 Of note, the incidence and kinetics of granulo- difference in activation of the contact system in the differ-
entially susceptible rat strains. Because the activation ofmatous hepatitis and anemia are similar in Lewis rats
injected intraperitoneally or subserosally with PG- prekallikrein to kallikrein and the inhibition of kallikrein
by plasma protease inhibitors were similar, the defectAPS.10,11,20 Previous studies in the subserosal PG-APS
Lewis rat model have only evaluated single time points seemed to be localized to the high-molecular-weight ki-
ninogen molecule. This conclusion was supported by aduring acute and chronic phases and have not docu-
mented spontaneous reactivation of inflammation.4,5 In direct demonstration that purified plasma kallikrein
preliminary studies, we have incriminated T-lympho- cleaves high-molecular-weight kininogen in Lewis
cytes in the pathogenesis of the chronic, relapsing phase plasma more rapidly than in Buffalo plasma. The nature
of intestinal and systemic inflammation in Lewis rats of the resistance of Buffalo rat high-molecular-weight
after intramural PG-APS injection.54 kininogen to cleavage is unknown; potential mechanisms
include protein polymorphism or posttranslational modi-This study clearly shows a differential host genetic
fications such as glycosylation. The reproducible differ-susceptibility to bacterial cell wall polymers in inbred
ence in high-molecular-weight kininogen cleavage inrat strains. Lewis rats developed chronic, granulomatous
vitro by kallikrein is compelling because there is evidenceenterocolitis with fibrosis and extraintestinal inflamma-
tion, whereas Buffalo rats showed a self-limited course of for prekallikrein activation in vivo (significant decrease
/ 5e0d$$0018 04-18-96 16:26:54 gasas WBS-Gastro
1478 SARTOR ET AL. GASTROENTEROLOGY Vol. 110, No. 5
in functional prekallikrein) in Lewis but not in Buffalo injection in our current study, high-molecular-weight
kininogen values in Lewis rats injected intraperitoneallyrats. The significance in the pathogenesis of experimental
intestinal inflammation is not fully understood, but the with PG-APS were no different than those of control
rats during chronic inflammation (23 and 45 days),20efficacy of a kallikrein inhibitor57 in PG-PS–induced
enterocolitis in Lewis rats speaks for an important contri- although plasma prekallikrein concentrations were sig-
nificantly decreased at all time points in both studies.bution by the contact system. In addition, this pathway
may be important in other tissues because experimental Activation of the contact system in PG-APS–induced
enterocolitis and systemic disease is similar to that ob-arthritis induced by PG-APS is also blocked by a kalli-
krein inhibitor.21 served in clinical sepsis,60 typhoid fever,61 and Rocky
Mountain spotted fever62 and in volunteers administeredSeveral other alterations in immunoresponsiveness
endotoxin (lipopolysaccharide).63 Thus, it is evident thathave been postulated to determine host genetic suscepti-
the bacterial cell wall polymers lipopolysaccharide andbility in Lewis rats to chronic inflammation. Our previous
PG-APS share the ability to activate the contact systemstudies have shown an increased ratio of interleukin 1
in vivo. The preliminary observation that the contactmessenger RNA to its endogenous inhibitor interleukin
system is activated in active ulcerative colitis64 is consis-1 receptor antagonist in chronically inflamed intestinal
tent with our findings in experimental enterocolitis. Intissues of Lewis rats injected subserosally with PG-APS
a prospective study of Rocky Mountain spotted fever,relative to acutely injured Fischer rats, but no difference
the contact system was activated at the earliest stages,was observed with Buffalo rats.4 Similarly, Sternberg et
suggesting a pathogenic role in the inflammatory re-al.9 have shown defective hypothalamic production of
sponse.62 More convincing demonstrations of a causalcorticotropin-releasing hormone in Lewis rats relative to
role for the contact system in systemic inflammation isFischer rats in response to short-term systemic adminis-
provided by attenuation of disseminated intravasculartration of interleukin 1 or PG-APS. Additionally, these
coagulation in experimental porcine gram-negative sepsisinvestigators showed enhanced local production of corti-
by recombinant a1 -antitrypsin Pittsburgh
65 and the abil-cotropin-releasing hormone and cyclooxygenase in the
ity of a monoclonal antibody to factor XII to block theinflamed joints of Lewis rats after intraperitoneal PG-
late phase of hypotension and enhance survival in baboonsAPS injection but no up-regulation of local corticotro-
infused with Escherichia coli.66pin-releasing hormone or cyclooxygenase synthesis in
noninflamed Fischer rats.58,59 These results can be criti- Active inflammation and tissue damage may be accom-
panied by complex alterations of zymogens and cofactorscized because Fischer rats fail to develop arthritis after
intraperitoneal PG-APS injection; therefore, increased ar- as a result of activation of the contact system.22 The
observed decrease in plasma prekallikrein and high-mo-ticular corticotropin-releasing hormone and cyclooxygen-
ase production could be a consequence rather than the lecular-weight kininogen levels in our rat model of gran-
ulomatous enterocolitis and systemic inflammation maycause of the inflammatory response. In contrast, our cur-
rent results show no evidence of activation of the contact be caused by consumption of precursor proteins as they
are converted to active enzymes or cofactors or, alterna-system of Buffalo rats during a time of active intestinal
inflammation and anemia, indicating that consumption tively, by changes in the rate of synthesis and degradation
of these zymogens. Our results support contact activationof plasma prekallikrein and high-molecular-weight ki-
ninogen is not merely secondary to the inflammatory with consumption of precursor proteins as the underlying
process. The normal antithrombin III and factor XI levelsresponse. This interpretation is strongly supported by
defective in vitro high-molecular-weight kininogen shown during acute and chronic phases of inflammation
make significant liver disease (i.e., decreased synthesis)cleavage in activated plasma from normal Buffalo rats
and inhibition of PG-APS–induced inflammation in much less likely.
Lewis rats by selective plasma kallikrein blockade.21,57 Activation of kallikrein and bradykinin could induce
intestinal injury in Lewis rats by several mechanisms.We have shown previously activation of the contact
system during acute and chronic phases of systemic in- Kallikrein stimulates neutrophil aggregation and de-
granulation,25,26 which could contribute to the increasedflammation induced by intraperitoneal PG-APS injection
in Lewis rats.20 Plasma functional high-molecular-weight numbers of neutrophils in inflamed tissues during acute
and chronic phases of enterocolitis induced by PG-APS,kininogen concentrations inversely correlated with acute
arthritis scores (5 days after intraperitoneal PG-APS in- as documented by increased acute-phase histological
scores and myeloperoxidase values. High-molecular-jection). In contrast to the decrease in plasma high-mo-
lecular-weight kininogen values at 42 days after PG-APS weight kininogen serves as a cofactor for kallikrein for-
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Mucosal injury and inflammation in a model of chronic granuloma-mation,22 providing a potential mechanism by which
tous enterocolitis. Gastroenterology 1993;104:759–771.a selective defect in high-molecular-weight kininogen 6. Schwab JH. Phlogistic properties of peptidoglycan-polysacchara-
activation in Buffalo rats could also inhibit kallikrein ide polymers from cell walls of pathogenic and normal-flora bacte-
ria which colonize humans. Infect Immun 1993;61:4535–4539.activation. In addition, a change in one amino acid, at
7. Stimpson SA, Brown RR, Anderle SK, Klapper DG, Clark RL, Cro-or near the cleavage site on the Buffalo high-molecular-
martie WJ, Schwab JH. Arthropathic properties of cell wall poly-
weight kininogen for plasma kallikrein, would inhibit mers from normal flora bacteria. Infect Immun 1986;51:240–
249.high-molecular-weight kininogen cleavage. Bradykinin
8. Severijnen AJ, Hazenberg MP, Van de Merwe JP. Induction ofcould directly induce tissue edema in experimental en-
chronic arthritis in rats by cell wall fragments of anaerobic coc-
terocolitis by virtue of its ability to enhance vascular coid rods isolated from the faecal flora of patients with Crohn’s
permeability22 and to stimulate arachidonic acid metabo- disease. Digestion 1988;39:118–125.
9. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ,lites.67 Factor XIIa (cleaved by kallikrein) and bradykinin
Gold PW, Wilder RL. Inflammatory mediator-induced hypotha-stimulate interleukin 1 production,68,69 and interleukin
lamic-pituitary-adrenal activation is defective in streptococcal cell
1 dramatically up-regulates the ability of bradykinin to wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA
1989;86:2374–2378.release arachidonic acid metabolites.67,69 Tissue concen-
10. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia L, Hunt AR. Bacte-trations of interleukin 1 messenger RNA and protein are
rial cell wall– induced hepatic granulomas: an in vivo model of T
increased during acute and chronic phases of PG-APS– cell–dependent fibrosis. J Exp Med 1986;63:884–902.
induced enterocolitis and correlate with the degree of 11. Sartor RB, Anderle SK, Rifai N, Goo DA, Cromartie WJ, Schwab
JH. Protracted anemia associated with chronic, relapsing sys-tissue injury.4
temic inflammation induced by arthropathic peptidoglycan-poly-
In summary, we describe a unique rat model of saccharide polymers in rats. Infect Immun 1989;57:1177–
chronic, spontaneously relapsing, granulomatous entero- 1185.
12. Griffiths MM, DeWitt CW. Genetic control of collagen-induced ar-colitis with associated extraintestinal inflammation. This
thritis in rats: the immune response to type II collagen amongmodel can be used to investigate mechanisms of geneti-
susceptible and resistant strains and evidence for multiple gene
cally determined host susceptibility to chronic intestinal control. J Immunol 1984;132:2830–2836.
13. Sartor RB, Bender D, Holt LC. Susceptibility of inbred rat strainsinflammation, thereby providing new insights into the
to intestinal and extraintestinal inflammation induced by indo-pathogenesis of Crohn’s disease. Our demonstration of
methacin (abstr). Gastroenterology 1992;102:A690.
selective in vivo and in vitro activation of the contact 14. Lichtman SN, Sartor RB, Schwab JH, Keku J. Hepatic inflamma-
system in genetically susceptible Lewis rats, correlation tion in rats with experimental small bowel bacterial overgrowth.
Gastroenterology 1990;98:414–423.of plasma high-molecular-weight kininogen and plasma
15. Davis JK, Thorp RB, Maddox PA, Brown MB, Cassell GH. Murineprekallikrein with chronic inflammation, and attenuation
respiratory mycoplasmosis in F344 and LEW rats: evolution of
of intestinal57 and systemic inflammation21 by specific lesions and lung lymphoid cell populations. Infect Immun 1982;
36:720–729.kallikrein blockade suggest that the kallikrein/kinin
16. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelinpathway is integrally involved in the pathogenesis of
basic protein and natural recovery from experimental autoim-
granulomatous enterocolitis and associated systemic mune encephalomyelitis are associated with downregulation of
inflammatory cytokines and differential upregulation of trans-complications. These results provide a firm rationale for
forming growth factor, interleukin 4, and prostaglandin E expres-exploration of the contact system in Crohn’s disease and
sion in the brain. J Exp Med 1992;176:1355–1364.
a justification for attempts to block components of this 17. Bristol LA, Durum SK, Eisenberg SP. Differential regulation of
system in experimental and clinical chronic intestinal group A streptococcal peptidoglycan-polysaccharide (PG-APS)-
stimulated macrophage production of IL-1 by rat strains suscepti-inflammation.
ble and resistant to PG-APS–induced arthritis. Cell Immunol
1993;149:130–143.
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